YLR278C Antibody

What is YLR278C and why is it significant in yeast research?

YLR278C is a gene in Saccharomyces cerevisiae (strain ATCC 204508/S288c) that encodes the protein with UniProt accession number Q05854. This protein is significant in yeast research because it serves as a model for understanding fundamental cellular processes that are conserved across eukaryotes. The YLR278C gene product is involved in cellular pathways that can provide insights into basic biological mechanisms such as protein trafficking, cellular metabolism, or stress responses. Studying this protein through antibody-based techniques allows researchers to track its expression, localization, and interactions under various experimental conditions, contributing to our understanding of yeast cellular biology .

What are the recommended applications for YLR278C antibody in yeast research?

The YLR278C antibody is recommended for multiple experimental applications in yeast research, including Western blotting, immunoprecipitation, immunofluorescence microscopy, chromatin immunoprecipitation (ChIP), and enzyme-linked immunosorbent assays (ELISA). These techniques allow researchers to detect the presence, abundance, localization, and interactions of the target protein in various experimental contexts. For optimal results, researchers should validate the antibody specificity in their particular strain and experimental conditions, as antibody performance can vary depending on the specific yeast strain genetic background and growth conditions .

What are the optimal storage and handling conditions for YLR278C antibody?

The YLR278C antibody should be stored at -20°C for long-term preservation of activity. For short-term storage (up to one month), the antibody can be kept at 4°C. Repeated freeze-thaw cycles should be avoided as they can lead to protein denaturation and loss of antibody activity. When handling the antibody, it's advisable to aliquot it into smaller volumes upon receipt to minimize freeze-thaw cycles. The antibody should be stored in its original buffer with a carrier protein (typically BSA) and preservative. When working with the antibody, maintain sterile conditions and use clean, RNase/DNase-free consumables to prevent contamination. The stability of the antibody under recommended storage conditions is typically maintained for at least 12 months from the date of receipt .

What controls should be included when using YLR278C antibody for the first time?

When using YLR278C antibody for the first time in an experimental setup, several controls should be included to ensure reliable and interpretable results. A positive control consisting of a wild-type yeast strain known to express the YLR278C protein should be included. Conversely, a negative control using a YLR278C knockout strain should be tested to confirm antibody specificity. Including a loading control (such as an antibody against a housekeeping protein like actin) is essential for normalization. Additionally, a secondary antibody-only control should be included to identify any non-specific binding of the secondary antibody. For immunofluorescence applications, pre-immune serum or isotype controls can help establish background staining levels. Finally, peptide competition assays, where the antibody is pre-incubated with the immunizing peptide, can confirm binding specificity .

How should sample preparation be optimized for detecting YLR278C in yeast lysates?

Optimizing sample preparation for detecting YLR278C in yeast lysates requires attention to several key factors. First, select an appropriate lysis method that preserves the native structure of the protein while efficiently disrupting the yeast cell wall. Common methods include mechanical disruption (glass beads, sonication), enzymatic lysis (zymolyase), or a combination of both. The lysis buffer composition is critical and should typically contain protease inhibitors, reducing agents, and appropriate detergents. For membrane-associated proteins, stronger detergents may be necessary. The lysis conditions (temperature, pH, salt concentration) should be optimized based on the protein's characteristics. After lysis, samples should be cleared by centrifugation to remove cell debris. For Western blotting applications, protein denaturation conditions (temperature, reducing agents) may need optimization to ensure proper epitope exposure. Sample storage conditions should also be considered, with freshly prepared lysates generally yielding the best results .

How can YLR278C antibody be used for protein localization studies in yeast?

For protein localization studies, YLR278C antibody can be employed in immunofluorescence microscopy following specific methodological guidelines. Begin by fixing yeast cells with formaldehyde (typically 3.7%) for 30-60 minutes, followed by cell wall digestion using zymolyase or lyticase to create spheroplasts, which improves antibody penetration. Permeabilize the cells with a detergent like Triton X-100 (0.1-0.5%) to allow antibody access to intracellular compartments. Blocking with BSA or normal serum (5-10%) reduces non-specific binding. Incubate cells with YLR278C primary antibody at optimized dilutions (typically 1:100 to 1:500) for 1-3 hours at room temperature or overnight at 4°C. After washing, apply fluorophore-conjugated secondary antibody and counterstain the nucleus with DAPI. Use confocal microscopy for high-resolution imaging and colocalization studies with organelle markers to determine precise subcellular localization. Time-course experiments following induction or stress can reveal dynamic changes in protein distribution, while 3D reconstruction may provide spatial context for the protein's location within the cell .

What are the key considerations for troubleshooting weak or absent signals when using YLR278C antibody?

When encountering weak or absent signals with YLR278C antibody, systematic troubleshooting involves assessing multiple experimental parameters. First, verify antibody quality through dot blot analysis with the immunizing peptide. Check antibody concentration – typically, 1-5 μg/ml for Western blot and immunofluorescence – and consider titrating to find optimal concentrations. Examine protein expression conditions, as YLR278C may be expressed only under specific growth phases or stress conditions. Evaluate sample preparation by testing alternative lysis buffers and ensuring complete protein extraction from yeast cells through efficient cell wall disruption. For Western blots, optimize protein denaturation conditions and transfer efficiency. Increase signal sensitivity by using enhanced detection systems like chemiluminescent substrates with longer exposure times or amplification steps. Consider epitope accessibility issues by testing different fixation methods or antigen retrieval techniques. If protein abundance is naturally low, enrichment through immunoprecipitation prior to detection may be necessary. Additionally, cross-reactivity with similar proteins can be assessed through peptide competition assays and validation in knockout strains .

How can protein-protein interactions of YLR278C be investigated using antibody-based approaches?

Investigating protein-protein interactions of YLR278C requires sophisticated antibody-based techniques. Co-immunoprecipitation (Co-IP) serves as the primary method, where cell lysates are incubated with YLR278C antibody to capture the protein complex, followed by Western blot analysis to identify interacting partners. Crosslinking prior to lysis can stabilize transient interactions. Proximity ligation assay (PLA) provides in situ detection of protein interactions by generating fluorescent signals when two proteins are within 40nm of each other. For larger protein complexes, immunoprecipitation followed by mass spectrometry (IP-MS) allows unbiased identification of multiple interaction partners. Chromatin immunoprecipitation (ChIP) can determine if YLR278C associates with specific DNA regions, while sequential ChIP (re-ChIP) can identify protein complexes at specific genomic loci. Bimolecular fluorescence complementation (BiFC) and Förster resonance energy transfer (FRET) provide visual confirmation of interactions in living cells. Pull-down assays using recombinant proteins can validate direct interactions identified through these methods. Each approach has specific strengths and limitations, and multiple complementary techniques should be employed for comprehensive interaction mapping .

What strategies can improve the specificity of YLR278C antibody in complex yeast protein samples?

Improving YLR278C antibody specificity in complex yeast samples requires multifaceted approaches. Pre-adsorption against yeast lysates lacking the target protein (from knockout strains) can remove antibodies recognizing non-specific epitopes. Affinity purification of the antibody using immobilized target protein or immunizing peptide enriches for specific antibodies. Optimizing blocking conditions with 5% non-fat milk or BSA in TBS-T with additional yeast proteins can reduce background binding. Increasing wash stringency through higher salt concentrations (150-500mM NaCl) or mild detergents (0.1-0.5% Triton X-100) in wash buffers removes weakly bound antibodies. Titrating antibody concentrations to find the optimal signal-to-noise ratio is essential, typically starting with manufacturer recommendations and adjusting as needed. Using knockout or knockdown strains as negative controls confirms signal specificity. For Western blots, transferring to PVDF rather than nitrocellulose membranes may improve signal-to-noise ratio for some antibodies. Competition assays with excess immunizing peptide can identify non-specific signals. Finally, two-dimensional electrophoresis before Western blotting can separate proteins with similar molecular weights but different isoelectric points, further enhancing specificity .

How should quantitative analysis of YLR278C expression be performed across different experimental conditions?

Quantitative analysis of YLR278C expression across different experimental conditions requires rigorous methodological approaches. Western blotting with carefully optimized protocols serves as the foundation, using digital image capture systems and densitometry software for quantification. Multiple technical and biological replicates (minimum n=3) are essential for statistical validity. Normalization to housekeeping proteins (actin, GAPDH) or total protein (Ponceau S staining) accounts for loading variations. Standard curves using recombinant YLR278C protein enable absolute quantification. For higher throughput, quantitative dot blots or ELISA can be employed, though with potentially reduced specificity. Flow cytometry following cell fixation and permeabilization allows single-cell quantification if antibody performance permits. RT-qPCR provides complementary mRNA level data, though post-transcriptional regulation may cause discrepancies with protein levels. For spatial distribution analysis, quantitative immunofluorescence microscopy with appropriate controls and calibration standards enables subcellular expression mapping. Statistical analysis should include appropriate tests based on data distribution, with multiple comparison corrections when analyzing numerous conditions. Combining these approaches provides comprehensive understanding of YLR278C expression patterns under various experimental manipulations .

How can YLR278C antibody be adapted for high-throughput screening applications?

Adapting YLR278C antibody for high-throughput screening requires systematic optimization and automation. Begin by developing a robust ELISA protocol with the antibody immobilized on 96- or 384-well plates, then validate signal linearity, reproducibility, and Z-factor scores (>0.5 indicates suitable assay quality). For cell-based screens, fix yeast cells in microplates and perform automated immunostaining with optimized antibody concentrations. Implement automated liquid handling systems for consistent reagent dispensing and washing steps to minimize variation between plates. Establish clear positive and negative controls on each plate for normalization and quality control. Consider using fluorescently-labeled secondary antibodies with automated plate readers or high-content imaging systems for quantitative readouts. For even higher throughput, adapt to multiplex bead-based assays (such as Luminex) that allow simultaneous detection of multiple proteins. Develop automated image analysis pipelines for consistent quantification across thousands of samples. Implement statistical methods appropriate for high-throughput data, including normalization algorithms to account for plate-to-plate variation and robust statistical tests to identify true hits while controlling false discovery rates. Finally, validate screening hits with orthogonal methods to confirm the biological relevance of identified modulators of YLR278C expression or function .

What approaches can distinguish between post-translational modifications of YLR278C protein?

Distinguishing between post-translational modifications (PTMs) of YLR278C protein requires sophisticated analytical techniques. Phosphorylation-specific antibodies can be used if available, but more comprehensive approaches include combining immunoprecipitation with YLR278C antibody followed by mass spectrometry analysis. This approach can identify and quantify multiple PTMs simultaneously, including phosphorylation, acetylation, ubiquitination, and SUMOylation. For phosphorylation specifically, treatment with lambda phosphatase followed by mobility shift analysis on Phos-tag™ acrylamide gels can reveal the presence and extent of phosphorylation. Two-dimensional gel electrophoresis separates protein isoforms based on both molecular weight and isoelectric point, allowing visualization of differently modified forms. Targeted proteomics approaches like selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) can quantify specific modified peptides. Chemical labeling techniques such as iTRAQ or TMT enable comparison of modification levels across multiple experimental conditions. For temporal dynamics of modifications, pulse-chase experiments combining YLR278C antibody with modification-specific detection methods can track modification turnover. Bioinformatic prediction tools can guide the investigation by identifying likely modification sites based on consensus sequences. Finally, functional studies using mutation of modification sites can validate the biological significance of identified PTMs .

How can YLR278C antibody be utilized in chromatin immunoprecipitation (ChIP) studies?

Utilizing YLR278C antibody in chromatin immunoprecipitation (ChIP) studies requires specific protocol adaptations. First, determine if the YLR278C protein interacts with DNA directly or as part of a DNA-binding complex through literature searches or preliminary tests. Crosslink yeast cells with formaldehyde (typically 1%) for 10-15 minutes to stabilize protein-DNA interactions, followed by quenching with glycine. Lyse cells and isolate chromatin, then sonicate to generate DNA fragments of 200-500bp. Set aside input control samples before immunoprecipitation. Optimize antibody concentration (typically 2-5μg per ChIP reaction) and incubation conditions (overnight at 4°C with rotation). Use protein A/G magnetic beads for efficient capture of antibody-chromatin complexes. Include appropriate controls: IgG negative control, positive control antibody targeting known DNA-binding proteins, and when possible, samples from YLR278C knockout strains. After extensive washing with increasingly stringent buffers, reverse crosslinks and purify DNA. Analyze enrichment through quantitative PCR targeting candidate regions or through genome-wide approaches like ChIP-seq. For ChIP-seq, include spike-in controls for normalization and prepare libraries following standard protocols. Bioinformatic analysis should identify binding peaks, motifs, and genomic features associated with YLR278C localization. Integration with transcriptomic data can reveal functional significance of YLR278C binding to specific genomic regions .

How does the performance of YLR278C antibody compare across different yeast strains and species?

When working with non-S288C strains, researchers should perform careful validation experiments including Western blot analysis comparing multiple strains, peptide competition assays, and when possible, testing with gene deletion strains to confirm specificity .

What are the most common causes of data misinterpretation when using YLR278C antibody?

Data misinterpretation when using YLR278C antibody commonly stems from several methodological and analytical pitfalls. Cross-reactivity with structurally similar proteins can generate false positive signals, particularly in closely related yeast strains or when using polyclonal antibodies. This can be identified and mitigated through knockout strain controls and peptide competition assays. Background signals from non-specific binding may be misinterpreted as genuine protein expression, especially when using high antibody concentrations or insufficient blocking. Inadequate normalization to loading controls leads to misinterpretation of apparent expression differences that actually reflect sample loading variation. Over-reliance on single techniques without orthogonal validation can produce technique-specific artifacts rather than biologically relevant findings. Post-translational modifications can alter epitope accessibility, causing apparent expression changes that actually reflect modification state differences. For quantitative analyses, using non-linear detection methods without establishing a linear range leads to saturation effects and inaccurate quantification. Confirmation bias may lead researchers to focus on expected bands while ignoring unexpected results that could indicate specificity issues. Finally, extrapolating from artificial overexpression systems to endogenous conditions often overlooks significant differences in protein folding, localization, and interaction networks that affect antibody recognition. Robust controls, method validation, and triangulation across multiple techniques are essential to avoid these common interpretive errors .

How should contradictory results between YLR278C antibody detection and genetic expression data be resolved?

Resolving contradictory results between YLR278C antibody detection and genetic expression data requires systematic investigation of multiple potential causes. First, examine temporal dynamics, as protein levels often lag behind mRNA changes, creating apparent discrepancies in time-course experiments. Post-transcriptional regulation through mechanisms like miRNA targeting, RNA-binding proteins, or altered mRNA stability can cause protein abundance to deviate from transcript levels. Post-translational modifications or protein conformational changes may affect epitope accessibility without changing protein abundance, creating false impressions of expression changes. Technical factors including antibody specificity issues, sample preparation differences, or detection method limitations should be methodically evaluated. Cross-reactivity with related proteins can be assessed through immunoprecipitation followed by mass spectrometry to identify all proteins recognized by the antibody. To resolve discrepancies, implement orthogonal protein detection methods like targeted mass spectrometry that don't rely on epitope recognition. Genetic approaches including epitope tagging can provide independent verification of protein expression. Subcellular fractionation may reveal compartmentalization effects where total protein remains constant but localization changes. Time-course experiments with fine temporal resolution can identify transient changes missed in single-timepoint analyses. For definitive resolution, consider creating reporter systems like fluorescent protein fusions to directly monitor both transcript and protein dynamics simultaneously in living cells. Documenting all experimental conditions precisely helps identify variables contributing to discrepant results .

How can super-resolution microscopy enhance YLR278C localization studies?

Super-resolution microscopy techniques offer transformative capabilities for YLR278C localization studies by overcoming the diffraction limit of conventional microscopy. Structured Illumination Microscopy (SIM) provides approximately 100nm resolution, enabling visualization of YLR278C distribution within yeast organelles with twice the detail of confocal microscopy. For even higher resolution, Stimulated Emission Depletion (STED) microscopy can achieve 30-50nm resolution, revealing protein clustering and microdomain organization previously undetectable. Single-molecule localization methods like PALM and STORM offer exceptional 10-20nm resolution by precisely localizing individual fluorophores over time, though these techniques require specialized fluorophore-conjugated secondary antibodies with appropriate photoswitching properties. Expansion microscopy physically enlarges specimens after immunolabeling, providing an alternative approach to visualize nanoscale protein distribution. For optimal results with super-resolution, sample preparation must be meticulously optimized with particular attention to fixation methods that preserve nanoscale structures while maintaining epitope accessibility. Multi-color super-resolution imaging can reveal previously undetectable spatial relationships between YLR278C and other cellular components. Quantitative analysis of super-resolution data provides statistical insights into protein clustering, nearest-neighbor distances, and colocalization at nanoscale dimensions. Dynamic super-resolution approaches can track YLR278C movement at nanoscale precision in minimally perturbed cells, revealing functional mechanisms invisible to conventional microscopy .

What emerging antibody engineering approaches might improve YLR278C detection specificity?

Emerging antibody engineering approaches offer promising avenues for improving YLR278C detection specificity. Single-domain antibodies (nanobodies) derived from camelid heavy-chain antibodies provide exceptional specificity due to their small size (~15kDa) and unique binding properties, potentially accessing epitopes unavailable to conventional antibodies. Recombinant antibody fragment technologies, including scFv (single-chain variable fragments) and Fab fragments, can be engineered with optimized binding sites specifically targeting unique regions of YLR278C. Phage display technology enables in vitro selection of antibodies with extremely high specificity and affinity through iterative binding and selection cycles against the purified target protein. Synthetic antibody libraries created through combinatorial protein engineering provide additional diversity beyond natural immune repertoires. Site-specific mutagenesis of existing antibodies can enhance specificity by modifying complementarity-determining regions (CDRs) based on structural data. Bispecific antibodies simultaneously targeting two distinct epitopes on YLR278C dramatically increase specificity through avidity effects. Antibody-oligonucleotide conjugates enable highly specific proximity-based detection methods like proximity ligation assays. Computational antibody design using machine learning algorithms can predict optimal binding interfaces for specific YLR278C epitopes. For exceptionally challenging applications, alternative binding scaffolds like DARPins, Affibodies, or Monobodies offer recognition molecules with tailored specificity that can complement or replace traditional antibodies when epitope accessibility or specificity present persistent challenges .